Merck Sharp & Dohme Limited

Hertford Road, Hoddesdon, Hertfordshire, EN11 9BU
Telephone: +44 (0)1992 467 272
Fax: +44 (0)1992 479 292
Medical Information e-mail: medicalinformationuk@merck.com

Patient Information Leaflet last updated on the eMC: 17/08/2011
PIL Propecia 1mg tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 17/08/2011 and displayed until Current
Reasons for adding or updating:
  • Change to side-effects
Updated on 28/04/2010 and displayed until 17/08/2011
Reasons for adding or updating:
  • Change to side-effects
Updated on 26/09/2008 and displayed until 28/04/2010
Reasons for adding or updating:
  • Change due to user-testing of patient information
  • Change to warnings or special precautions for use
Updated on 27/09/2006 and displayed until 26/09/2008
Reasons for adding or updating:
  • Introduction of new pack
Updated on 16/02/2005 and displayed until 27/09/2006
Reasons for adding or updating:
  • Change to side-effects
Updated on 12/03/2002 and displayed until 16/02/2005
Reasons for adding or updating:
  • Update to PIL
Updated on 30/07/2001 and displayed until 12/03/2002
Reasons for adding or updating:
  • Update to PIL
Updated on 26/10/2000 and displayed until 30/07/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   finasteride